Boxer Capital LLC 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:33 pm Sale |
2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
Boxer Capital LLC | 0 0.000% |
-1,675,377 (Position Closed) |
Filing |
| 2020-12-18 07:22 am Purchase |
2020-12-08 | 13G | ARS Pharmaceuticals, Inc. SPRY |
Boxer Capital LLC | 1,675,377 4.800% |
3 (+0.00%) |
Filing |
| 2020-12-17 4:37 pm Purchase |
2020-12-08 | 13G | ARS Pharmaceuticals, Inc. SPRY |
Boxer Capital LLC | 1,675,374 4.800% |
1,675,374 (New Position) |
Filing |